PALO ALTO A Stanford research team has created a potentially powerful new way to fix damaged corneas a major source of vision problems and blindness.
Millions of new eye cells are being grown in a Palo Alto lab, enlisting one of medicines most important and promising new tools: refurbishing diseased and damaged tissue with healthy new cells.
One of the exciting possibilities of this cellular approach is that one donor cornea, which contributes a few parent cells, can generate enough cells to treat tens or hundreds of patients, said lead researcher Dr. Jeffrey Goldberg, professor and chairman of the Department of Ophthalmology at the Stanford University School of Medicine.
About 100,000 corneal transplants are done annually in the United States but they require surgery with donated corneas from cadavers. The procedure fails nearly a third of the time, and there arent enough high-quality donor corneas to go around.
Other scientists have been trying to grow full corneas from scratch, attaching a fragile film of cells to a membrane. Thats a challenging bioengineering problem.
Stanfords innovative strategy, eight years in the making, is to grow individual cells instead. The team then harvests a few mother corneal cells, called progenitor cells, donated from a cadaver.
These cells are then put into a warm broth in petri dishes, where they give birth to many new young corneal cells.
The cells are being grown at Stanfords new Laboratory for Cell and Gene Medicine, a 25,000-square-foot biological manufacturing facility on Palo Altos California Avenue.
The Stanford team enlisted a recent technological advance: magnetic nanoparticles. The particles are incredibly small, measuring only 50 nanometers in diameter. By comparison, a human hair is 75,000 nanometers in diameter.
The new young cells were magnetized with the nanoparticles, loaded into a syringe and injected into the eye.Then, using an electromagnetic force on a patch held outside of the eye, the team pulled the cells into the middle of the eye, to the back of cornea. Later, the magnetic nanoparticles fell off the cells, exited the eye and were excreted in the patients urine.
Ultimately, Goldberg said, the team hopes to mass produce off-the-shelf cells that can be easily transplanted into patients with severe damage to the cornea, the transparent outer coating of the eye that covers the iris and pupil.
In the first trial of 11 patients, a so-called Phase 1 trial, the team only studied safety.
Not only was the procedure safe, but we are seeing hints of efficacy that we are very excited about, Goldberg said. Were cautiously optimistic.
The Stanford team plans to expand the study in September to Phase 2 to measure how the vision of the patients improves.
The effort has been endorsed by the American Academy of Ophthalmology, which says it supports innovative clinical Many countries outside the United States and Europe have a shortage of donor eye tissue, leaving millions of people unable to obtain a donor cornea. If this early research is found to be safe and effective, this technique may help some patients avoid corneal transplant, said Dr. Philip R. Rizzuto, clinical spokesman for the American Academy of Ophthalmology.
If successful, the approach could also be used to replace other types of damaged eye cells, offering therapies for retinal and optic nerve diseases including glaucoma, the leading cause of irreversible blindness, he said.
The approach is part of an expanding field of lab-grown cell therapies. Sheets of healthy skin are used to treat burns, chronic skin wounds and diseases like epidermolysis bullosa, which causes incurable blistering. And bioengineered cartilage is increasingly used to treat certain knee injuries.
Stanford researchers believe that lab-grown corneal cells could become another important type of regenerative medicine.
Unlike other transplants, corneas in the Stanford teams approach dont have to be a perfect match. Rejection can be prevented with simple topical eyedrops.
Goldberg predicted that the approach could eventually replace about 80 percent of corneal transplants.
Specifically, it could repair the damaged inner layer of the cornea, called the endothelium, as seen in diseases like Fuchs dystrophy, which causes corneal damage due to swelling. It would not help in the 20 percent of transplants needed to fix the middle layer of the cornea, called the stroma.
Next month, the team will analyze its early Phase 1 data and also apply for permission from the U.S. Food and Drug Administration to begin Phase 2.
While relatively few people in the United States suffer diseases or injuries that cause devastating cornea damage, the numbers are much greater in developing nations, where infectious eye diseases remain common.
The new approach could offer a nonsurgical permanent solution in those countries, Goldberg said.
Half the world has no access to tissue, he said. I would love this to be one and done, solving patients problems for decades.
Read the original:
Stanford lab grows cornea cells for transplant – The Mercury News
- Exercise can help offset effects of 'fat gene,' study finds - ABC News - April 28th, 2017
- Stem cells edited to fight arthritis - Washington University School of Medicine in St. Louis - April 28th, 2017
- UVA Gene Mutation Research Method Speeds Precision Medicine - Health IT Analytics - April 28th, 2017
- Scientists and Students Share Insights at Computational Research Day - Northwestern University NewsCenter - April 28th, 2017
- When to Tell Daughters About a Genetic Breast Cancer Risk - New York Times - April 22nd, 2017
- Synpromics Raise 5.2m in its Latest Fundraising Round ... - Technology Networks - April 22nd, 2017
- Federal funding for basic research led to the gene-editing revolution. Don't cut it. - Vox - April 22nd, 2017
- Scientists discover gene that blocks spread of colon cancer - Medical Xpress - April 22nd, 2017
- Dermatology - Stanford University School of Medicine ... - April 18th, 2017
- Ambry Genetics Recruits Patient Cohorts to Discover New Links between Genes and Autism - Yahoo Finance - April 18th, 2017
- Enigmatic chemical tag is altered in autism brains - Spectrum - April 18th, 2017
- How a Single Gene Could Become a Volume Knob for Pain - WIRED - April 18th, 2017
- MiMedx To Present At 5th Annual Cell & Gene Therapy Investor Day - PR Newswire (press release) - April 18th, 2017
- All women should get tested for cancer gene, says scientist who led discovery - Champaign/Urbana News-Gazette - April 18th, 2017
- The Daily Pennsylvanian | How Penn Medicine and people from ... - The Daily Pennsylvanian - April 16th, 2017
- Gene Findings Advance Precision Medicine for Intellectual Disability - Genetic Engineering & Biotechnology News - April 15th, 2017
- Here's Another Way CRISPR Is Changing Medicine - TIME - April 15th, 2017
- Consensus Study on Human Gene Editing - National-Academies.org - April 15th, 2017
- WSU sleep researchers discover why some people may toss and turn more than others - The Spokesman-Review - April 15th, 2017
- Gene Editing Researcher Receives ASAN Award In Basic Medicine - Asian Scientist Magazine - April 15th, 2017
- Recent advances in experiment and study of prostate cancer targeted therapy - Benzinga - April 15th, 2017
- Gene-editing alternative corrects Duchenne muscular dystrophy - Science Daily - April 15th, 2017
- Cleveland Clinic's Medical Innovation Summit to focus on genomics and precision medicine - Crain's Cleveland Business - April 10th, 2017
- Kathy Castor visits USF College of Medicine, pledges to fight Donald Trump's NIH funding cuts - SaintPetersBlog (blog) - April 10th, 2017
- The gene that turns epilepsy treatment deadly - Medical Xpress - April 10th, 2017
- 'Sleep gene' offers clues about why we need our zzzs - WSU News - April 9th, 2017
- Too Much Information? FDA Clears 23AndMe to Sell Home Genetic Tests for Alzheimer's and Parkinson's - Scientific American - April 9th, 2017
- NKPD1 gene variant increases depression risk - Medical Xpress - April 4th, 2017
- Study reverses thinking on genetic links to stress, depression - Washington University School of Medicine in St. Louis - April 4th, 2017
- Screening the dark genome for disease - Science Daily - April 4th, 2017
- New gene discovered driving drug resistance - Medical Xpress - April 4th, 2017
- Gene Changes May Put Childhood Cancer Survivors at Risk - Montana Standard - April 4th, 2017
- 2017 Global Gene Medicine Therapy Market in North America ... - Edition Time - April 4th, 2017
- Study sheds light on dark side of tumor suppressor gene, p53 - Medical Xpress - April 4th, 2017
- Genetic errors associated with heart health may guide drug development - Science Daily - April 4th, 2017
- Meningitis bacteria adapting to STI niche, genetic analysis shows - Medical Xpress - April 4th, 2017
- Screening genome's 'dark matter' for risks - Durham Herald Sun - April 4th, 2017
- Canopy acquires gene-editing technology license - St. Louis Business Journal - April 4th, 2017
- Nicotine ameliorates schizophrenia cognitive deficits in mice [PreClinical] - 2 Minute Medicine - April 2nd, 2017
- MSK Expertise on Precision Medicine Highlighted in American Association for Cancer Research Annual Meeting Press ... - Memorial Sloan Kettering Cancer... - April 2nd, 2017
- Zallen: Genetic testing bill is modern eugenics - Roanoke Times - April 2nd, 2017
- Early-life BPA exposure reprograms gene expression linked to fatty liver disease - Medical Xpress - April 2nd, 2017
- Genetic errors associated with heart health may guide drug development - Washington University School of Medicine in St. Louis - April 2nd, 2017
- Genetic Errors Linked With Heart Health May Guide Drug Development - Bioscience Technology - April 1st, 2017
- NIH allergist awarded Drukier Prize by Weill Cornell Medicine - Cornell Chronicle - April 1st, 2017
- Fighting canine ALS - Medical Xpress - March 30th, 2017
- Genetic errors associated with heart health may guide drug development - Medical Xpress - March 30th, 2017
- Stem cells help explain varied genetics behind rare neurologic disease - Medical Xpress - March 30th, 2017
- Possible genetic marker for ALS found might prove useful for measuring effectiveness of treatments - Medical Xpress - March 30th, 2017
- Gene editing of human embryos yields early results - Science News - March 29th, 2017
- New Gene Interaction Appears to be Associated with Increased MS ... - Independent Tribune - March 29th, 2017
- Rare genetic mutation made Egyptian Eman the heaviest, says study - Hindustan Times - March 29th, 2017
- Study finds 12 genetic variants that raise the risk of ovarian cancer - Medical News Today - March 29th, 2017
- Scientists Spot Gene for Rare Disorder Causing Deafness, Blindness - Montana Standard - March 27th, 2017
- Researchers develop new tool for gene delivery - ScienceBlog.com (blog) - March 27th, 2017
- OTUD6B gene mutations cause intellectual, physical disability - Baylor College of Medicine News (press release) - March 27th, 2017
- Testing the efficacy of new gene therapies more efficiently - Science Daily - March 21st, 2017
- Gene editing technique helps find cancer's weak spots -- ScienceDaily - Science Daily - March 21st, 2017
- A Cure for Clara: Gene therapy developed at Auburn University set for human trials - Alabama's News Leader - March 21st, 2017
- Scientists find possible Achilles heel of treatment-resistant cancers - Medical Xpress - March 21st, 2017
- 'For us, this means hope': Exploring the promise of genomic medicine - Chicago Tribune - March 18th, 2017
- New 'gene silencer' drug reduce cholesterol by over 50 percent - Science Daily - March 18th, 2017
- Gene ABL1 implicated in cancer, developmental disorder - Baylor College of Medicine News (press release) - March 18th, 2017
- Here's Why Editas Medicine Gained as Much as 17.2% Today - Motley Fool - March 15th, 2017
- Anorexia Nervosa Modeled in a Dish, Risk Gene Uncovered - Genetic Engineering & Biotechnology News - March 15th, 2017
- Gene mutation found to drive prostate cancer subtype - Medical Xpress - March 15th, 2017
- Gene Expression's Big Rethink - Genetic Engineering & Biotechnology News - March 15th, 2017
- Workplace Genetic Testing Isn't Just Unethical, It's Scientifically Unsound - Huffington Post - March 15th, 2017
- Collected Wisdom: Dr. Val Gene Iven combines love of sports with medicine - NewsOK.com - March 12th, 2017
- Taking A Second Look - ChicagoNow (blog) - March 12th, 2017
- The First Results of Gene Editing in Normal Embryos Have Been Released - Futurism - March 12th, 2017
- 3 Huge Healthcare Trends and How to Invest in Them (Hint: One Is Marijuana) - Motley Fool - March 12th, 2017
- Gene that causes rare disorder, Opitz C syndrome, identified - Science Daily - March 12th, 2017
- Teen's Sickle Cell Disease 'Reversed' with Groundbreaking Therapy - Reader's Digest - March 11th, 2017
- Precision Medicine Project Mulls How to Return Genetic Test Results to 1M Participants - GenomeWeb - March 11th, 2017
- Rocky Hill Obituary: Dr. Eugene Rotatori, 84 - Patch.com - March 11th, 2017
- Researchers find a gene that causes Opitz C syndrome - Medical Xpress - March 10th, 2017
- Sickle Cell Gene Tied to Higher ESRD Risk - MedPage Today - March 10th, 2017
- Social phobia: Indication of a genetic cause - Medical Xpress - March 10th, 2017
- Mutations in CWC27 result in spectrum of conditions - Baylor College of Medicine News (press release) - March 10th, 2017
Recommendation and review posted by Guinevere Smith